HONG KONG, March 3, 2024 /PRNewswire/ — DPC Dash Ltd (“DPC Dash” or the “Company”, together with its subsidiaries, the “Group”) (1405.HK), Domino’s Pizza’s exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special…
Month: March 2024
HONG KONG, March 3, 2024 /PRNewswire/ — DPC Dash Ltd (“DPC Dash” or the “Company”, together with its subsidiaries, the “Group”) (1405.HK), Domino’s Pizza’s exclusive master franchisee in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special…
SEOUL, South Korea, March 3, 2024 /PRNewswire/ — CHEQUER Inc., a leading B2B SaaS cyber security platform startup, announced today that it has closed an investment round, positioning the company for accelerated expansion in the global market and innovation in the cloud native security…
SEOUL, South Korea, March 3, 2024 /PRNewswire/ — CHEQUER Inc., a leading B2B SaaS cyber security platform startup, announced today that it has closed an investment round, positioning the company for accelerated expansion in the global market and innovation in the cloud native security…
TOKYO, March 3, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced dosing of the first patient in the STARLIGHT™ 2 Phase 3 pivotal study for fezolinetant, an investigational oral, nonhormonal compound being studied for the…
Hugel becomes the first and only Korean company that have market approvals in all three major aesthetic markets – U.S., Europe and China U.S. is the largest and fastest growing aesthetic market globally at USD 2.5 bn in 2023, and expected to nearly double to USD 4.9 bn by 2031 SEOUL,…
– CBL-514 is the first and only drug to receive both Orphan Drug Designation and Fast Track designation for Dercum’s disease treatment. NEW TAIPEI CITY, March 3, 2024 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted…